Géraldine Laumond
0000-0003-1867-0734
Publication & Citation Trends
Publications
0 total
Neutralizing nanobodies against SARS-CoV-2 recognizing highly conserved epitopes at the Spike's S2 subunit.
Cited by 0
Semantic Scholar
Deciphering HIV vaccine-induced antibody response according to ethnicity
Cited by 1
Semantic Scholar
Potent HIV-1 miniprotein inhibitors targeting highly conserved gp41 epitopes.
Cited by 3
Semantic Scholar
Investigating vulnerability of the conserved SARS-CoV-2 spike's heptad repeat 2 as target for fusion inhibitors using chimeric miniproteins. OA
Cited by 4
Semantic Scholar
Safety and immunogenicity of CD40.HIVRI.Env, a dendritic cell-based HIV vaccine, in healthy HIV-uninfected adults: a first-in-human randomized, placebo-controlled, dose-escalation study (ANRS VRI06) OA
Cited by 8
Semantic Scholar
Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activity OA
Cited by 11
Semantic Scholar
Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies OA
Cited by 15
Semantic Scholar
Identification of early-induced broadly neutralizing activities against transmitted founder HIV strains OA
Cited by 1
Semantic Scholar
Research Topics
HIV Research and Treatment
(30)
HIV/AIDS drug development and treatment
(18)
Monoclonal and Polyclonal Antibodies Research
(9)
Immune Cell Function and Interaction
(8)
SARS-CoV-2 and COVID-19 Research
(7)
Affiliations
Inserm
EM Strasbourg Business School
Institut de Virologie
Fédération Hospitalo-Universitaire, Paris Center for Microbiome Medicine
Immuno-Rhumathologie moléculaire